MISTRAS Q2 revenue misses estimates

Reuters
Aug 07
MISTRAS <a href="https://laohu8.com/S/QTWO">Q2</a> revenue misses estimates

Overview

  • MISTRAS Q2 revenue falls 2.3%, missing analyst expectations, per LSEG data

  • Net income for Q2 misses estimates at $3.0 mln, per LSEG data

  • Adjusted EBITDA hits $24.1 mln, beating analyst forecasts, per LSEG data

Outlook

  • Company expects 2025 Adjusted EBITDA to surpass 2024 levels

  • MISTRAS not providing full-year guidance for fiscal 2025

  • Company assessing impact of U.S. trade policy changes on 2025 results

  • MISTRAS anticipates reduction in accounts receivable balances this year

Result Drivers

  • BUSINESS MIX - Improved business mix and operating efficiencies led to a 5.1% increase in gross profit

  • FOREIGN EXCHANGE LOSS - SG&A expenses rose due to a $2.8 mln foreign exchange loss

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Revenue

Miss

$185.40 mln

$185.70 mln (3 Analysts)

Q2 Net Income

Miss

$3 mln

$7.48 mln (3 Analysts)

Q2 Adjusted EBITDA

Beat

$24.10 mln

$20.40 mln (3 Analysts)

Q2 Gross Margin

29.1%

Q2 Gross Profit

$53.90 mln

Analyst Coverage

  • The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the integrated oil & gas peer group is "buy."

  • Wall Street's median 12-month price target for Mistras Group Inc is $11.50, about 31.2% above its August 5 closing price of $7.91

  • The stock recently traded at 10 times the next 12-month earnings vs. a P/E of 10 three months ago

Press Release: ID:nGNX741yZB

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10